Lipopolysaccharide-induced impairment of nitric oxide-mediated vasorelaxation and protective effects of nitric oxide synthesis inhibitors in isolated rat mesenteric arteries

Tomohiro Miike; Mamoru Kanda; Kazuyoshi Kunishiro; Hiroaki Shirahase

doi:10.1055/s-0031-1296293

Arzneimittelforschung, Table of Contents

Arzneimittelforschung 2010; 60(6): 315-319
DOI: 10.1055/s-0031-1296293

Vasodilators

Editio Cantor Verlag Aulendorf (Germany)

Lipopolysaccharide-induced impairment of nitric oxide-mediated vasorelaxation and protective effects of nitric oxide synthesis inhibitors in isolated rat mesenteric arteries

Tomohiro Miike

Research Laboratories, Kyoto Pharmaceutical Industries, Ltd., Kyoto, Japan

,

Mamoru Kanda

Research Laboratories, Kyoto Pharmaceutical Industries, Ltd., Kyoto, Japan

,

Kazuyoshi Kunishiro

Research Laboratories, Kyoto Pharmaceutical Industries, Ltd., Kyoto, Japan

,

Hiroaki Shirahase

Research Laboratories, Kyoto Pharmaceutical Industries, Ltd., Kyoto, Japan

› Author Affiliations

Abstract

Isolated rat mesenteric arteries were in-cubated with lipopolysaccharide (LPS) for 6 h and then mounted in an organ bath to investigate their responses to various relaxants. Exposure to LPS moderately reduced acetylcholine (ACh)-induced endothelium-dependent relaxation (EDR),and markedly reduced sodium nitroprusside (SNP)-induced endothelium-independent relaxation (EIR). It did not affect ACh-induced EDR under treatment with a nitric oxide synthase (NOS) inhibitor,which is mediated by an endothelium-derived hyperpolarizing factor (EDHF),and forskolin-induced EIR. N-(3-(Amino-methyl)benzyl)acetamidine (1400 W), an inducible nitric oxide synthase (iNOS) inhibitor, actinomycin D, an RNA polymer-ase inhibitor, cycloheximide, a protein synthesis inhibitor, and dexamethazone reduced the nitric oxide (NO) production and reversed the reduced ACh-induced EDR and SNP-induced EIR. In LPS-treated mesenteric artery, L-arginine-induced relaxation was not affected by removal of endothelium, indicating muscular inducible nitric oxide synthase (iNOS) induction. Pre-exposure to SNP (NO donor) also moderately reduced ACh-induced EDR and markedly reduced SNP-induced EIR with little effect on ACh-induced EDHF-mediated EDR. In conclusion, in vitro exposure to LPS desensitized vascular smooth muscle cells to endogenous and exogenous NO by overproduction of muscular iNOS-derived NO, and an iNOS inhibitor and iNOS induction inhibitors prevented the LPS-induced desensitization.

Key words

Acetylcholine - Endothelium - Endotoxin - iNOS - Mesenteric artery - Nitric oxide - Rat

Full Text

References

References
1 O’Brien Jr. JM, Ali NA, Aberegg SK, Abraham E. Sepsis. Am J Med. 2007; 120 (12) 1012-22
2 Parratt JR. Nitric oxide in sepsis and endotoxemia. J Antimicrob Chemother. 1998; 41 (Suppl) 31-9
3 Martich GD, Boujoukos AJ, Suffredini AF. Response of man to endotoxin. Immunobiology. 1993; 187 (3–5) 403-16
4 Baker CH, Sutton ET. Arteriolar endothelium-dependent vasodilation occurs during endotoxin shock. Am J Physiol. 1993; 264 (4 Pt 2) H1118-23
5 Fatehi-Hassanabad Z, Parratt JR, Furman BL. Endotoxininduced inhibition of mesenteric vasodilator responses to acetylcholine, bradykinin, and post-occlusion hyperemia in anesthetized rats. Shock. 1996; 6 (5) 371-6
6 Mead PS, Guo JP, Lefer AM, Pierce S, Palladino M. Protective effects of a monoclonal antibody against lipid A in endotoxic shock. Methods Find Exp Clin Pharmacol. 1994; 16 (6) 405-12
7 Piepot HA, Boer C, Groeneveld AB, vanLambalgen AA, Sipkema P. Lipopolysaccharide impairs endothelial nitric oxide synthesis in rat renal arteries. Kidney Int. 2000; 57 (6) 2502-10
8 Piepot HA, Groeneveld AB, vanLambalgen AA, Sipkema P. Endotoxin impairs endothelium-dependent vasodilation more in the coronary and renal arteries than in other arteries of the rat. J Surg Res. 2003; 110 (2) 413-8
9 Boer C, Groeneveld AB, Scheffer GJ, deLange JJ, Westerhof N, Sipkema P. Induced nitric oxide impairs relaxation but not contraction in endotoxin-exposed rat pulmonary arteries. J Surg Res. 2005; 127 (2) 197-202
10 Mitsumizo S, Nakashima M, Hamada T, Totoki T. NOS II inhibition restores attenuation of endothelium-dependent hyperpolarization in rat mesenteric artery exposed to lipo-polysaccharide. J Cardiovasc Pharmacol. 2004; 43 (4) 589-94
11 Babu BR, Griffith OW. Design of isoform-selective inhibitors of nitric oxide synthase. Curr Opin Chem Biol. 1998; 2 (4) 491-500
12 Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ et al 1400 W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem. 1997; 272 (8) 4959-63
13 Oplinger JA, Garvey EP, Furfine ES, Shearer BG, Collins JL inventors; Wellcome Foundation Ltd., assignee. Acetami-dine derivatives and their use as inhibitors for the nitric oxide synthase. World patent WO9619440 1996 June 27
14 Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A. Alterations in endothelium-dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin-induced diabetic rats. Br J Pharmacol. 1997; 121 (7) 1383-91
15 Shirahase H, Kanda M, Nakamura S, Tarumi T, Uehara Y, Ichikawa A. Inhibitory effects of PGD₂, PGJ₂ and 15-deoxy-D^12,14-PGJ₂ on iNOS induction in rat mesenteric artery. Life Sci. 2000; 66 (22) 2173-82
16 Sayed N, Baskaran P, Ma X, vandenAkker F, Beuve A. De-sensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci USA. 2007; 104 (30) 12312-7
17 Chauhan SD, Seggara G, Vo PA, Macallister RJ, Hobbs AJ, Ahluwalia A. Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J. 2003; Apr 17 (6) 773-5